Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 11 studies | 22% ± 6% | |
fibroblast | 6 studies | 20% ± 4% | |
astrocyte | 6 studies | 24% ± 8% | |
oligodendrocyte | 5 studies | 23% ± 6% | |
macrophage | 5 studies | 21% ± 5% | |
microglial cell | 4 studies | 19% ± 3% | |
epithelial cell | 4 studies | 34% ± 11% | |
GABAergic neuron | 4 studies | 33% ± 7% | |
glutamatergic neuron | 4 studies | 39% ± 9% | |
placental villous trophoblast | 3 studies | 41% ± 2% | |
retinal pigment epithelial cell | 3 studies | 31% ± 11% | |
ciliated cell | 3 studies | 22% ± 3% | |
oligodendrocyte precursor cell | 3 studies | 25% ± 5% | |
basal cell | 3 studies | 26% ± 2% | |
interneuron | 3 studies | 35% ± 12% | |
neuron | 3 studies | 31% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 1147.15 | 459 / 459 | 100% | 6.00 | 1118 / 1118 |
esophagus | 100% | 607.89 | 1445 / 1445 | 100% | 7.78 | 183 / 183 |
ovary | 100% | 893.31 | 180 / 180 | 100% | 6.92 | 430 / 430 |
prostate | 100% | 787.41 | 245 / 245 | 100% | 5.80 | 502 / 502 |
stomach | 100% | 512.91 | 359 / 359 | 100% | 5.03 | 286 / 286 |
uterus | 100% | 905.56 | 170 / 170 | 100% | 6.76 | 459 / 459 |
lung | 100% | 890.97 | 578 / 578 | 100% | 5.64 | 1154 / 1155 |
kidney | 100% | 553.82 | 89 / 89 | 100% | 4.80 | 900 / 901 |
thymus | 100% | 905.07 | 653 / 653 | 100% | 5.83 | 604 / 605 |
intestine | 100% | 724.58 | 966 / 966 | 100% | 4.96 | 526 / 527 |
bladder | 100% | 648.29 | 21 / 21 | 100% | 5.54 | 503 / 504 |
brain | 100% | 524.44 | 2630 / 2642 | 100% | 6.72 | 705 / 705 |
liver | 100% | 590.81 | 226 / 226 | 100% | 3.37 | 404 / 406 |
adrenal gland | 100% | 580.05 | 258 / 258 | 99% | 4.17 | 228 / 230 |
pancreas | 99% | 324.05 | 324 / 328 | 99% | 5.36 | 177 / 178 |
skin | 100% | 889.37 | 1809 / 1809 | 97% | 5.42 | 458 / 472 |
adipose | 100% | 1081.81 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 3.70 | 29 / 29 |
spleen | 100% | 649.36 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 4.74 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.78 | 1 / 1 |
blood vessel | 100% | 744.08 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 490.91 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 399.21 | 852 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 10.89 | 79 / 80 |
peripheral blood | 68% | 229.66 | 629 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016567 | Biological process | protein ubiquitination |
GO_0007283 | Biological process | spermatogenesis |
GO_2001244 | Biological process | positive regulation of intrinsic apoptotic signaling pathway |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0060070 | Biological process | canonical Wnt signaling pathway |
GO_0051402 | Biological process | neuron apoptotic process |
GO_1990000 | Biological process | amyloid fibril formation |
GO_0030163 | Biological process | protein catabolic process |
GO_0009653 | Biological process | anatomical structure morphogenesis |
GO_0006915 | Biological process | apoptotic process |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0007399 | Biological process | nervous system development |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0007411 | Biological process | axon guidance |
GO_0005634 | Cellular component | nucleus |
GO_0030877 | Cellular component | beta-catenin destruction complex |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0005515 | Molecular function | protein binding |
GO_0031624 | Molecular function | ubiquitin conjugating enzyme binding |
Gene name | SIAH1 |
Protein name | E3 ubiquitin-protein ligase (EC 2.3.2.27) Siah E3 ubiquitin protein ligase 1 E3 ubiquitin-protein ligase SIAH1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1) (Siah-1) (Siah-1a) |
Synonyms | HUMSIAH |
Description | FUNCTION: E3 ubiquitin-protein ligase that mediates ubiquitination and subsequent proteasomal degradation of target proteins . E3 ubiquitin ligases accept ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates . Mediates E3 ubiquitin ligase activity either through direct binding to substrates or by functioning as the essential RING domain subunit of larger E3 complexes . Triggers the ubiquitin-mediated degradation of many substrates, including proteins involved in transcription regulation (ELL2, MYB, POU2AF1, PML and RBBP8), a cell surface receptor (DCC), the cell-surface receptor-type tyrosine kinase FLT3, the cytoplasmic signal transduction molecules (KLF10/TIEG1 and NUMB), an antiapoptotic protein (BAG1), a microtubule motor protein (KIF22), a protein involved in synaptic vesicle function in neurons (SYP), a structural protein (CTNNB1) and SNCAIP . Confers constitutive instability to HIPK2 through proteasomal degradation . It is thereby involved in many cellular processes such as apoptosis, tumor suppression, cell cycle, axon guidance, transcription regulation, spermatogenesis and TNF-alpha signaling . Has some overlapping function with SIAH2 . Induces apoptosis in cooperation with PEG3 (By similarity). Upon nitric oxid (NO) generation that follows apoptotic stimulation, interacts with S-nitrosylated GAPDH, mediating the translocation of GAPDH to the nucleus (By similarity). GAPDH acts as a stabilizer of SIAH1, facilitating the degradation of nuclear proteins (By similarity). Mediates ubiquitination and degradation of EGLN2 and EGLN3 in response to the unfolded protein response (UPR), leading to their degradation and subsequent stabilization of ATF4 (By similarity). Also part of the Wnt signaling pathway in which it mediates the Wnt-induced ubiquitin-mediated proteasomal degradation of AXIN1 . . FUNCTION: E3 ubiquitin-protein ligase that mediates ubiquitination and subsequent proteasomal degradation of target proteins. E3 ubiquitin ligases accept ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. . |
Accessions | ENST00000563745.1 B5BU17 ENST00000356721.3 [Q8IUQ4-2] ENST00000380006.2 [Q8IUQ4-1] H3BU09 ENST00000568007.5 [Q8IUQ4-1] Q8IUQ4 ENST00000394725.3 [Q8IUQ4-1] |